Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep-Nov;1(5-6):189-92.
doi: 10.1111/j.1750-2659.2007.00027.x.

Chloroquine is effective against influenza A virus in vitro but not in vivo

David J Vigerust  1 , Jonathan A McCullers
Affiliations

Chloroquine is effective against influenza A virus in vitro but not in vivo

David J Vigerust et al. Influenza Other Respir Viruses. 2007 Sep-Nov.

Abstract

Background: Chloroquine is an inexpensive and widely available 9-aminoquinolone used in the management of malaria. Recently, in vitro assays suggest that chloroquine may have utility in the treatment of several viral infections including influenza.

Objectives: We sought to test whether chloroquine is effective against influenza in vivo in relevant animal models.

Methods: The effectiveness of chloroquine at preventing or ameliorating influenza following viral challenge was assessed in established mouse and ferret disease models.

Results: Although active against influenza viruses in vitro, chloroquine did not prevent the weight loss associated with influenza virus infection in mice after challenge with viruses expressing an H1 or H3 hemagglutinin protein. Similarly, clinical signs and viral replication in the nose of ferrets were not altered by treatment.

Conclusions: Although in vitro results were promising, chloroquine was not effective as preventive therapy in vivo in standard mouse and ferret models of influenza virus infection. This dampens enthusiasm for the potential utility of the drug for humans with influenza.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of chloroquine (CQ) on influenza virus infection in mice. (A) Groups of nine mice were infected with influenza viruses PR8 (H1N1) or HK68 (H3N2), dosed with 12.5 mg/kg/day of chloroquine starting 24 hours prior to infection, and followed for weight loss (mean ± SD) compared to mock‐treated animals. (B) Groups of five mice were infected with HK68, dosed with either 25 or 37.5 mg/kg/day of chloroquine starting 24 hours prior to infection, and followed for weight loss compared to mock‐treated animals. An asterisk (*) indicates a significant difference in weight loss compared to the other groups at that time point (P < 0.05 by anova).
Figure 2
Figure 2
Effect of chloroquine (CQ) on influenza virus infection in ferrets. Groups of four ferrets were infected with Syd97 (H3N2), dosed with 10 mg/kg/day of chloroquine starting 24 hours prior to infection, and compared to untreated animals. (A) Rectal temperatures were monitored daily. Ferrets anesthetized with ketamine had 2 ml of sterile saline introduced into their noses to induce sneezing and the effluent captured in order to assay (B) protein content by the Bradford assay and (C) viral titer on MDCK cells. Values are presented as the mean ± SD. An asterisk (*) indicates a significant difference in viral titer compared to the other group at that time point (P < 0.05 by anova).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. McCullers JA. Antiviral therapy of influenza. Expert Opin Investig Drugs 2005;14:305–312. - PubMed
    1. Stohr K. Preventing and treating influenza. BMJ 2003;326:1223–1224. - PMC - PubMed
    1. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005‐2006 influenza season in the United States. JAMA 2006;295:891–894. - PubMed
    1. Kiso M, Mitamura K, Sakai‐Tagawa Y et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 2004;364:759–765. - PubMed
    1. Le QM, Kiso M, Someya K et al. Avian flu: isolation of drug‐resistant H5N1 virus. Nature 2005;437:1108. - PubMed

Publication types